참고문헌
- Alain S, Mazeron MC, Pepin JM, Bergmann JF, Narwa R, Raskine L, Sanson-Le Pors MJ. 1995. Value of a new rapid non-radioactive sequencing method for analysis of the cytomegalovirus UL97 gene in ganciclovir-resistant strains. J. Virol. Methods 51: 241-251. https://doi.org/10.1016/0166-0934(94)00110-3
- Centers for Disease Control and Prevention. 2000. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm. Rep. 49(RR-10): 11-14.
- Chou S. 2008. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev. Med. Virol. 18: 233-246. https://doi.org/10.1002/rmv.574
- Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL, et al. 1995. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis. 171: 576-583. https://doi.org/10.1093/infdis/171.3.576
- Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, et al. 1998. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from three subjects receiving prolonged antiviral therapy. J. Infect. Dis. 178: 526-530. https://doi.org/10.1086/515648
- Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, et al. 1997. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J. Infect. Dis. 176: 786-789. https://doi.org/10.1086/517302
- Chou S, Van Wechel LC, Lichy HM, Marousek GI. 2005. Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene. Antimicrob. Agents Chemother. 49: 2710-2715. https://doi.org/10.1128/AAC.49.7.2710-2715.2005
- Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, et al. 2002. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J. Infect. Dis. 185: 162-169. https://doi.org/10.1086/338362
- Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. 1995. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J. Infect. Dis. 172: 239-242. https://doi.org/10.1093/infdis/172.1.239
- Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, et al. 1999. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir. J. Infect. Dis. 179: 1352-1355. https://doi.org/10.1086/314747
- Eckle T, Jahn G, Hamprecht K. 2003. High impact of an expanded restriction fragment length polymorphism assay on detection of ganciclovir-resistant UL97 mutants of human cytomegalovirus. Antimicrob. Agents Chemother. 47: 442-443. https://doi.org/10.1128/AAC.47.1.442-443.2003
- Erice A, Gil-Roda C, Perez JL, Balfour HH, Sannerud KJ, Hanson MN, et al. 1997. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J. Infect. Dis. 175: 1087-1092. https://doi.org/10.1086/516446
- Erice A, Chou S, Biron KK, Stanat SC, Balfour Jr HH, Jordan MC. 1989. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N. Engl. J. Med. 320: 289-293. https://doi.org/10.1056/NEJM198902023200505
- Hanks SK, Quinn AM, Hunter T. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52. https://doi.org/10.1126/science.3291115
- Ijichi O, Michel D, Mertens T, Miyata K, Eizuru Y. 2002. GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E. Antiviral Res. 53: 135-142. https://doi.org/10.1016/S0166-3542(01)00202-9
- Jabs DA, Enger C, Dunn JP, Forman M. 1998. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. J. Infect. Dis. 177: 770-773. https://doi.org/10.1086/514249
- Lee GC, Lee DG, Choi SM, Yoo JH, Park SH, Choi JH, et al. 2005. Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir. J. Clin. Microbiol. 43: 5003-5008. https://doi.org/10.1128/JCM.43.10.5003-5008.2005
- Michel D, Höhn S, Haller T, Jun D, Mertens T. 2001. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein. J. Med. Virol. 65: 70-76. https://doi.org/10.1002/jmv.2003
- Prix L, Hamprecht K, Holzhuter B, Handgretinger R, Klingebiel T, Jahn G. 1999. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J. Infect. Dis. 180: 491-495. https://doi.org/10.1086/314877
- Sanchez Puch SI, Mathet VL, Porta M, Cuestas ML, Oubina JR, Videla CM, Salomon HE. 2009. Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation. Antiviral Res. 84: 194-198. https://doi.org/10.1016/j.antiviral.2009.08.005
- Sanchez Puch S, Ochoa C, Carballal G, Zala C, Cahn P, Brunet R, et al. 2004. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. J. Clin. Virol. 30: 271-275. https://doi.org/10.1016/j.jcv.2003.11.003
- Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR, Spector SA. 1997. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J. Infect. Dis. 176: 69-77. https://doi.org/10.1086/514041
- Tanaka K, Hori T, Yoto Y, Hatakeyama N, Yamamoto M, Suzuki N, Tsutsumi H. 2011. Human cytomegalovirus UL97 D605E polymorphism has a high prevalence in immunocompetent Japanese infants and children. Microbiol. Immunol. 55: 328-330. https://doi.org/10.1111/j.1348-0421.2011.00327.x
- Zhou L, Fan J, Zheng SS, Ma WH. 2006. Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China. Transplant. Proc. 38: 2926-2928. https://doi.org/10.1016/j.transproceed.2006.08.161
피인용 문헌
- Human cytomegalovirus pUL97 drug-resistance mutations in congenitally neonates and HIV-infected, no-drug-treated patients vol.12, pp.1, 2017, https://doi.org/10.2217/fvl-2016-0089